125 related articles for article (PubMed ID: 477712)
1. Pharmacokinetics of bromocriptine during continuous oral treatment of Parkinson's disease.
Friis ML; Grøn U; Larsen NE; Pakkenberg H; Hvidberg EF
Eur J Clin Pharmacol; 1979 May; 15(4):275-80. PubMed ID: 477712
[TBL] [Abstract][Full Text] [Related]
2. Bromocriptine concentration in saliva plasma after long-term treatment of patients with Parkinson's disease.
Friis ML; Johnsen T; Larsen NE; Hvidberg EF; Pakkenberg H
Eur J Clin Pharmacol; 1980 Aug; 18(2):171-4. PubMed ID: 7428799
[TBL] [Abstract][Full Text] [Related]
3. Agonist substitution in advanced Parkinson's disease.
Goetz CG; Shannon KM; Tanner CM; Carroll VS; Klawans HL
Neurology; 1989 Aug; 39(8):1121-2. PubMed ID: 2761708
[TBL] [Abstract][Full Text] [Related]
4. A six-month multicentre, double-blind, bromocriptine-controlled study of the safety and efficacy of ropinirole in the treatment of patients with Parkinson's disease not optimally controlled by L-dopa.
Brunt ER; Brooks DJ; Korczyn AD; Montastruc JL; Stocchi F;
J Neural Transm (Vienna); 2002 Apr; 109(4):489-502. PubMed ID: 11956968
[TBL] [Abstract][Full Text] [Related]
5. Bromocriptine: problems with low-dose de novo therapy in Parkinson's disease.
Grimes JD; Delgado MR
Clin Neuropharmacol; 1985; 8(1):73-7. PubMed ID: 3978651
[TBL] [Abstract][Full Text] [Related]
6. Plasma bromocriptine levels, clinical and growth hormone responses in Parkinsonism.
Price P; Debono A; Parkes JD; Marsden CD; Rosenthaler J
Br J Clin Pharmacol; 1978 Oct; 6(4):303-9. PubMed ID: 359016
[TBL] [Abstract][Full Text] [Related]
7. Determination of bromocriptine in plasma: comparison of gas chromatography, mass fragmentography and liquid chromatography.
Larsen NE; Ohman R; Larsson M; Hvidberg EF
J Chromatogr; 1979 Jul; 174(2):341-9. PubMed ID: 546893
[TBL] [Abstract][Full Text] [Related]
8. Long-term treatment of Parkinson's disease with bromocriptine.
Rascol A; Guiraud B; Montastruc JL; David J; Clanet M
J Neurol Neurosurg Psychiatry; 1979 Feb; 42(2):143-50. PubMed ID: 422961
[TBL] [Abstract][Full Text] [Related]
9. Treatment of parkinson's disease with bromocriptine.
Lieberman A; Kupersmith M; Estey E; Goldstein M
N Engl J Med; 1976 Dec; 295(25):1400-4. PubMed ID: 989885
[TBL] [Abstract][Full Text] [Related]
10. Bromocriptine versus placebo in levodopa treated patients with Parkinson's disease.
Gron U
Acta Neurol Scand; 1977 Sep; 56(3):269-73. PubMed ID: 333855
[TBL] [Abstract][Full Text] [Related]
11. [Bromocriptine as the 1st treatment of Parkinson's disease. Long term results].
Rascol A; Montastruc JL; Guiraud-Chaumeil B; Clanet M
Rev Neurol (Paris); 1982; 138(5):401-8. PubMed ID: 7146724
[TBL] [Abstract][Full Text] [Related]
12. Combined bromocriptine-levodopa therapy early in Parkinson's disease.
Rinne UK
Neurology; 1985 Aug; 35(8):1196-8. PubMed ID: 4022354
[TBL] [Abstract][Full Text] [Related]
13. A randomised controlled study comparing bromocriptine to which levodopa was later added, with levodopa alone in previously untreated patients with Parkinson's disease: a five year follow up.
Montastruc JL; Rascol O; Senard JM; Rascol A
J Neurol Neurosurg Psychiatry; 1994 Sep; 57(9):1034-8. PubMed ID: 8089666
[TBL] [Abstract][Full Text] [Related]
14. Bromocriptine versus levodopa in early Parkinson's disease.
Ramaker C; van Hilten JJ
Cochrane Database Syst Rev; 2000; (3):CD002258. PubMed ID: 10908538
[TBL] [Abstract][Full Text] [Related]
15. A double-blind study of bromocriptine and L-dopa in de novo Parkinson's disease. Short-term results.
Riopelle RJ; Gawel MJ; Libman I; King DB; McLean DR; Paulseth R; Raphy B; Bouchard S
Eur Neurol; 1988; 28 Suppl 1():11-4. PubMed ID: 3288477
[TBL] [Abstract][Full Text] [Related]
16. Bromocriptine in Parkinson disease.
Lieberman AN; Goldstein M
Pharmacol Rev; 1985 Jun; 37(2):217-27. PubMed ID: 3901046
[TBL] [Abstract][Full Text] [Related]
17. [Long-term results of treatment of Parkinson's disease with bromocriptine and domperidone (author's transl)].
Agid Y; Quinn N; Lhermitte F
Rev Neurol (Paris); 1981; 137(1):49-51. PubMed ID: 7232966
[TBL] [Abstract][Full Text] [Related]
18. Dopamine receptors: effects of chronic L-dopa and bromocriptine treatment in an animal model of Parkinson's disease.
Schneider MB; Murrin LC; Pfeiffer RF; Deupree JD
Clin Neuropharmacol; 1984; 7(3):247-57. PubMed ID: 6435870
[TBL] [Abstract][Full Text] [Related]
19. Early combination of bromocriptine and levodopa in Parkinson's disease: a prospective randomized study of two parallel groups over a total follow-up period of 44 months including an initial 8-month double-blind stage.
Giménez-Roldán S; Tolosa E; Burguera JA; Chacón J; Liaño H; Forcadell F
Clin Neuropharmacol; 1997 Feb; 20(1):67-76. PubMed ID: 9037575
[TBL] [Abstract][Full Text] [Related]
20. Low-dose bromocriptine in the early phases of Parkinson's disease.
Tolosa E; Blesa R; Bayes A; Forcadell F
Clin Neuropharmacol; 1987 Apr; 10(2):168-74. PubMed ID: 3332610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
